Pharmacokinetics, pharmacodynamics, and safety of clevidipine after prolonged continuous infusion in subjects with mild to moderate essential hypertension

PURPOSE: Clevidipine is a rapidly-acting intravenous dihydropyridine antihypertensive acting via calcium channel blockade. This was a randomized, single-blind, parallel-design study of a 72-h continuous clevidipine infusion. METHOD: Doses of 2, 4, 8, or 16.0 mg/h or placebo were evaluated in 61 subj...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Smith, William B., Marbury, Thomas C., Komjathy, Steven F., Sumeray, Mark S., Williams, Gregory C., Hu, Ming-yi, Mould, Diane R.
Format: Artigo
Jezik:Inglês
Izdano: Springer-Verlag 2012
Teme:
Pharmacodynamics
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3438395/
https://ncbi.nlm.nih.gov/pubmed/22457015
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00228-012-1260-3
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items